TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Octapharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,420,530
|
1,972,217
|
1,743,787 |
Financial expenses |
121
|
11,301
|
6,042 |
Earnings before taxes |
182,789
|
79,817
|
74,657 |
EBITDA |
387,201
|
295,199
|
312,708 |
Total assets |
1,851,898
|
1,332,866
|
1,741,651 |
Current assets |
673,310
|
420,907
|
736,279 |
Current liabilities |
384,381
|
339,775
|
263,462 |
Equity capital |
1,177,921
|
965,381
|
929,384 |
- share capital |
25,326
|
23,648
|
24,381 |
Employees (average) |
1,065
|
984
|
882 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.6%
|
72.4%
|
53.4% |
Turnover per employee |
2,273
|
2,004
|
1,977 |
Profit as a percentage of turnover |
7.6%
|
4.0%
|
4.3% |
Return on assets (ROA) |
9.9%
|
6.8%
|
4.6% |
Current ratio |
175.2%
|
123.9%
|
279.5% |
Return on equity (ROE) |
15.5%
|
8.3%
|
8.0% |
Change turnover |
308,371
|
280,838
|
-95,715 |
Change turnover % |
15%
|
17%
|
-5% |
Chg. No. of employees |
81
|
102
|
-6 |
Chg. No. of employees % |
8%
|
12%
|
-1% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.